Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. [electronic resource]
Producer: 20010208Description: 1973-8 p. digitalISSN:- 0269-9370
- Adult
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Drug Administration Schedule
- HIV Infections -- drug therapy
- HIV-1 -- isolation & purification
- Humans
- Indinavir -- administration & dosage
- Lamivudine -- adverse effects
- Pilot Projects
- RNA, Viral -- blood
- Reverse Transcriptase Inhibitors -- adverse effects
- Treatment Outcome
- Viral Load
- Zidovudine -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.